Wintest
6721
Ridge-i
5572
D. Western Therapeutics Institute
4576
River Eletec
6666
Forside
2330
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -13.28%40.9B | 110.41%144.05B | 6.77%31.02B | 105.63%36.09B | 321.87%29.78B | 218.60%47.16B | 84.94%68.46B | 189.80%29.05B | 1,426.00%17.55B | 843.85%7.06B |
Net profit before non-cash adjustment | 10.61%18.36B | 103.27%71.8B | 16.84%13.46B | 149.36%24.22B | 84.01%17.53B | 263.38%16.6B | -6.30%35.32B | -33.63%11.52B | 38.56%9.71B | 736.17%9.52B |
Total adjustment of non-cash items | -34.00%7.78B | -4.61%39.97B | -51.71%7.3B | -4.30%10.12B | 53.30%10.76B | 28.28%11.78B | 36.29%41.9B | 138.65%15.12B | 20.95%10.58B | 0.65%7.02B |
-Depreciation and amortization | 4.91%13.27B | 6.76%50.85B | 4.15%12.87B | 7.93%13.08B | 7.84%12.26B | 7.25%12.65B | 13.56%47.63B | 15.18%12.35B | 8.89%12.12B | 12.89%11.37B |
-Reversal of impairment losses recognized in profit and loss | ---- | -11.45%3.5B | 5.69%3.32B | ---- | ---- | ---- | --3.96B | --3.15B | ---217M | ---- |
-Share of associates | -84.92%-368M | -1,701.14%-4.74B | -15.69%-730M | -1,782.83%-3.33B | -293.39%-476M | -168.38%-199M | 0.38%-263M | -323.49%-631M | 3,860.00%198M | -395.12%-121M |
-Disposal profit | 661.54%198M | 158.26%594M | 976.47%149M | 421.92%381M | -59.14%38M | -67.90%26M | 206.67%230M | 63.04%-17M | -34.23%73M | 156.02%93M |
-Other non-cash items | -668.11%-5.32B | -6.10%-10.25B | -3,224.06%-8.31B | 88.41%-185M | 80.21%-1.06B | 76.75%-693M | 12.31%-9.66B | 106.34%266M | 36.19%-1.6B | -80.06%-5.35B |
Changes in working capital | -21.40%14.76B | 468.55%32.28B | 324.62%10.26B | 163.64%1.74B | 115.79%1.5B | 1,691.70%18.78B | 72.12%-8.76B | 117.69%2.42B | 81.24%-2.74B | -28.75%-9.49B |
-Change in receivables | 255.62%8.13B | 586.71%9.3B | 114.86%1.38B | 25.05%4.64B | 112.63%999M | -84.58%2.29B | 105.36%1.35B | 38.45%-9.27B | 114.22%3.71B | -148.01%-7.91B |
-Change in inventory | -71.14%2.83B | 3,373.27%20.82B | -12.35%4.05B | 196.66%7.2B | 87.64%-247M | 272.76%9.82B | 95.97%-636M | 363.92%4.62B | 208.93%2.43B | 77.59%-2B |
-Change in payables | -52.89%3.08B | 105.95%667M | -69.82%1.71B | -2.98%-9.12B | 569.43%1.53B | 179.42%6.55B | -181.73%-11.21B | -24.94%5.66B | -164.75%-8.86B | 101.45%229M |
-Provision for loans, leases and other losses | 513.11%748M | 2.16%1.47B | 150.81%3.11B | -1,039.53%-980M | -562.13%-781M | 7.02%122M | 178.63%1.44B | 163.91%1.24B | -72.00%-86M | -77.68%169M |
-Changes in other current assets | -571.43%-33M | -89.33%32M | -84.02%27M | -94.12%4M | -126.09%-6M | -82.50%7M | 113.39%300M | 106.85%169M | -2.86%68M | -72.62%23M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | 20.53%957M | 48.00%1.78B | 6,133.33%181M | 30.67%622M | -4.21%182M | 47.31%794M | 2.04%1.2B | -142.86%-3M | 7.21%476M | 578.57%190M |
Interest paid (cash flow from operating activities) | 58.60%-320M | -1.94%-3.67B | -66.79%-1.35B | 26.80%-680M | 16.44%-869M | 6.19%-773M | -39.54%-3.6B | -16.21%-810M | -69.84%-929M | -63.01%-1.04B |
Interest received (cash flow from operating activities) | 115.94%1.19B | 85.42%4.62B | 209.87%1.92B | 47.61%1.05B | 57.82%1.1B | 18.97%552M | 43.05%2.49B | 26.64%618M | 47.61%710M | 86.86%697M |
Tax refund paid | -72.61%-6.28B | -26.25%-18.41B | 7.34%-3.15B | -62.33%-6.2B | -48.33%-5.41B | 1.84%-3.64B | -50.34%-14.58B | -736.36%-3.4B | -105.49%-3.82B | -53.55%-3.65B |
Other operating cash inflow (outflow) | -1M | 0 | 0.00%-1M | 1M | 0 | 0 | -1M | 0.00%-1M | 0 | -1M |
Operating cash flow | -17.35%36.45B | 137.84%128.37B | 12.41%28.61B | 120.76%30.88B | 661.15%24.78B | 290.98%44.1B | 95.14%53.97B | 170.33%25.45B | 4,325.38%13.99B | 274.49%3.26B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -17.40%-10.68B | -2.29%-45.53B | -9.48%-13.02B | -14.08%-10.78B | -18.61%-12.64B | 27.35%-9.09B | 11.89%-44.51B | 19.87%-11.89B | 37.35%-9.45B | 15.46%-10.65B |
Net investment product transactions | -103.15%-4.91B | -65.73%4.74B | -5,247.79%-7.27B | 23.63%10.63B | 132.58%3.8B | -164.76%-2.42B | 267.56%13.82B | 97.26%-136M | 508.94%8.6B | 184.31%1.63B |
Net changes in other investments | 67.63%-268M | 108.65%109M | 984.87%1.05B | -8.90%-1.03B | 703.97%912M | -1,700.00%-828M | -92.07%-1.26B | -46.91%-119M | -468.67%-944M | -184.91%-151M |
Investing cash flow | -28.48%-15.85B | -27.33%-40.69B | -58.39%-19.24B | 34.26%-1.18B | 13.57%-7.93B | -39.64%-12.34B | 46.23%-31.95B | 38.92%-12.15B | 89.64%-1.8B | 37.14%-9.17B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 74.28%-1.56B | -86.60%-27.81B | -137.92%-2.56B | 1.07%-13.22B | 60.54%-5.95B | -189.51%-6.08B | -188.85%-14.9B | 24.42%6.75B | -249.03%-13.36B | -706.03%-15.08B |
Net common stock issuance | ---- | -816,000.00%-8.16B | ---1M | ---- | ---- | ---- | ---1M | --0 | ---- | ---- |
Increase or decrease of lease financing | 37.23%-602M | 0.19%-4.19B | 26.79%-1.07B | -7.00%-1.21B | -66.55%-956M | 7.61%-959M | -36.58%-4.2B | -42.33%-1.46B | -63.39%-1.13B | 3.04%-574M |
Cash dividends paid | -86.44%-7.22B | -23.71%-8.81B | 25.00%-3M | -26.79%-4.92B | -50.00%-15M | -19.99%-3.87B | 21.51%-7.12B | 0.00%-4M | 14.30%-3.88B | 23.08%-10M |
Cash dividends for minorities | 10.37%-2.35B | -51.63%-4.1B | -161.54%-80M | 70.00%-39M | -20.44%-1.36B | -66.43%-2.62B | -4.36%-2.71B | 345.28%130M | 65.43%-130M | -62.82%-1.13B |
Net other fund-raising expenses | 0.00%-2M | ---- | ---- | --0 | --0 | -100.61%-2M | 113.37%367M | 1,400.00%39M | --1M | --0 |
Financing cash flow | 13.28%-11.74B | -85.82%-53.07B | -167.91%-3.71B | -48.90%-27.54B | 50.68%-8.28B | -1,160.66%-13.53B | -1,394.56%-28.56B | 25.72%5.46B | -648.84%-18.5B | -1,511.60%-16.8B |
Net cash flow | ||||||||||
Beginning cash position | 38.69%146B | -3.55%105.27B | 58.51%136.74B | 41.46%131.14B | 10.78%128.58B | -3.55%105.27B | -18.55%109.15B | -23.14%86.26B | -25.95%92.7B | -17.42%116.07B |
Current changes in cash | -51.37%8.86B | 629.54%34.62B | -69.83%5.66B | 134.15%2.15B | 137.74%8.57B | 389.90%18.23B | 77.89%-6.54B | 406.05%18.76B | 55.93%-6.31B | -48.77%-22.71B |
Effect of exchange rate changes | 16.00%5.89B | 129.92%6.12B | 1,393.36%3.6B | 2,707.58%3.44B | -818.35%-6.01B | 58.53%5.08B | -43.45%2.66B | -92.07%241M | -109.71%-132M | -554.00%-654M |
Cash adjustments other than cash changes | 0.00%1M | ---- | ---- | ---- | ---3M | --1M | ---- | ---- | --0 | ---- |
End cash Position | 25.03%160.76B | 38.69%146B | 38.69%146B | 58.51%136.74B | 41.46%131.14B | 10.78%128.58B | -3.55%105.27B | -3.55%105.27B | -23.14%86.26B | -25.95%92.7B |
Free cash flow | -25.70%25.57B | 941.04%81.66B | 21.96%15.17B | 361.31%20B | 261.11%12.08B | 2,500.07%34.42B | 132.59%7.84B | 309.96%12.44B | 127.97%4.34B | 49.46%-7.5B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |